| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2561223 | Pharmacological Research | 2014 | 8 Pages |
Transforming growth factor β (TGF-β) belongs to a class of pleiotropic cytokines that are involved in the processes of embryonic development, wound healing, cell proliferation, and differentiation. Moreover, TGF-β is also regarded as a central regulator in the pathogenesis and development of various liver diseases because it contributes to almost all of the stages of disease progression. A range of liver cells are considered to secrete TGF-β ligands and express related receptors and, consequently, play a crucial role in the progression of liver disease via different signal pathways. In this manuscript, we review the role of the TGF-β signaling pathway in liver disease and the potential of targeting the TGF-β signaling in the pharmacological treatment of liver diseases.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (207 K)Download as PowerPoint slide
